Kevin O'Neill has deep leadership and commercialization expertise in vaccines (SARS CoV-2, HIV, pneumococcal, flu, RSV, CMV, EBV, HSV, TB, Noro, Dengue, etc,) rare disease, gene therapies and small molecule markets. Kevin has over 30 years of biopharma commercial management experience which results in objective, high-impact, strategic insights and expertly guided support in the execution of commercial strategies.✦✦ Expertise ✦✦• Strategy development• Commercialization• Global Launch planning ► positioning• Vaccine Development Strategy• Vaccine Commercialization• Product Launch Expert• Pneumococcal disease• Commercial Leadership• Portfolio analysis• Communications ► messaging• Dietary supplements ► consumer products• Marketing strategy• Business development• Product development• Alliance management• Flu and respiratory vaccines
Listed skills include Pharmaceutical Industry, Product Launch, Biotechnology, Strategy, and 33 others.